Split History
ETFs Holding BSPM »    BSPM Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biostar Pharmaceuticals is a holding company. Through its wholly-owned subsidiary, Shaanxi Biostar Biotech, Ltd. and its variable interest entities Shaanxi Aoxing Pharmaceutical Co., Ltd. and Shaanxi Weinan Huaren Pharmaceuticals Ltd., Co. develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in China. Co.'s primary product is the XinAoxing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. As of Dec 31 2015, Co. manufactured and sold 12 OTC medications and 17 prescription-based pharmaceuticals which were sold and distributed in over 25 provinces and provincial-level cities throughout China. According to our BSPM split history records, Biostar Pharmaceuticals has had 2 splits.
BSPM split history picture
Biostar Pharmaceuticals (BSPM) has 2 splits in our BSPM split history database. The first split for BSPM took place on April 04, 2012. This was a 1 for 3 reverse split, meaning for each 3 shares of BSPM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split. BSPM's second split took place on February 05, 2016. This was a 1 for 7 reverse split, meaning for each 7 shares of BSPM owned pre-split, the shareholder now owned 1 share. For example, a 333.333333333333 share position pre-split, became a 47.6190476190476 share position following the split.

When a company such as Biostar Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the BSPM split history from start to finish, an original position size of 1000 shares would have turned into 47.6190476190476 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biostar Pharmaceuticals shares, starting with a $10,000 purchase of BSPM, presented on a split-history-adjusted basis factoring in the complete BSPM split history. BSPM split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/29/2009
End date: 02/24/2017
Start price/share: $92.40
End price/share: $2.79
Dividends collected/share: $0.00
Total return: -96.98%
Average Annual Total Return: -38.66%
Starting investment: $10,000.00
Ending investment: $301.92
Years: 7.16
Date Ratio
04/04/20121 for 3
02/05/20161 for 7
BSPM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BSTC Split History
BSX Split History
BTX Split History
CAH Split History
CALA Split History
CAPR Split History
CASC Split History
CBIO Split History
CBLI Split History
CBM Split History

TearLab Corporation (TEAR)
Pareteum Corporation (TEUM)
MoSys, Inc. (MOSY)
Catalyst Biosciences, Inc. (CBIO)
GlassBridge Enterprises, Inc. (GLA)
Summit State Bank (SSBI)
Global Net Lease, Inc. (GNL)
Rennova Health, Inc. (RNVA)
Hennessy Advisors, Inc. (HNNA)
Comcast Corporation (CMCSA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BSPM Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.